| Literature DB >> 30512219 |
Alex Gomelsky1, Stavros Athanasiou2, Myung-Soo Choo3, Michel Cosson4, Roger R Dmochowski5, Cristiano M Gomes6, Ash Monga7, Charles W Nager8, Roy Ng9, Eric S Rovner10, Peter Sand11, Hikaru Tomoe12.
Abstract
Urinary incontinence is a prevalent condition worldwide and causes a tremendous impact on a woman's quality of life. While conservative and non-surgical therapies are options for treatment, surgery for stress urinary incontinence (SUI) is common. Options include colposuspension, slings (pubovaginal and midurethral), and periurethral bulking. While evidence supports each of these options in the treatment of SUI, each is associated with various rates of success and unique adverse event profiles. Urgency urinary incontinence (UUI) is initially treated with behavioral modification and pharmacologic means, with surgery reserved for those with refractory symptoms or significant complications from medication use. At present, intravesical onabotulinumtoxinA injections, percutaneous tibial nerve stimulation, and sacral neurostimulation are all viable options for refractory UUI/overactive bladder. As with surgical interventions for SUI, each of these is, likewise, associated with unique outcomes and adverse event profiles. Herein, we summarize the findings and conclusions from the 6th International Consultation on Incontinence (ICI) regarding surgical treatment of urinary incontinence in women.Entities:
Keywords: outcomes; surgery; urinary incontinence; women
Mesh:
Substances:
Year: 2018 PMID: 30512219 DOI: 10.1002/nau.23895
Source DB: PubMed Journal: Neurourol Urodyn ISSN: 0733-2467 Impact factor: 2.696